Need professional-grade analysis? Visit stockanalysis.com
$2.95B
13.64
20,300
N/A
Bausch Health Companies Inc (BHC) trades on Toronto Stock Exchange in CAD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CAD8.09, up 1.51% from the previous close.
Over the past year, BHC has traded between a low of CAD6.12 and a high of CAD11.52. The stock has gained 12.7% over this period. It is currently 29.8% below its 52-week high.
Bausch Health Companies Inc has a market capitalization of $2.95B, with a price-to-earnings ratio of 13.64.
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Side-by-side comparison against top Healthcare peers.